The Dietary Polyphenol Resveratrol in Intestinal Ischemia-Reperfusion Injury: From Multifaceted Protective Mechanisms to Clinical Translation Challenges
Zhang XF., Huang Z., Zeng Y., Zhang Y., Li P., Wang FX.
Clinical Trial on Face & Skin, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Food Sci Nutr (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42016267
- PMCID
- PMC13093332
- DOI
- 10.1002/fsn3.71666
- Citations
- 1
Abstract (original English)
Intestinal ischemia-reperfusion (I/R) injury constitutes a life-threatening condition with mortality approaching 50%, yet effective therapeutic interventions remain limited. Resveratrol, a natural polyphenolic compound, has demonstrated promising multi-targeted protective effects in preclinical models by simultaneously enhancing antioxidant defense, suppressing inflammatory cascades, inhibiting ferroptosis, stabilizing mast cells, and preserving intestinal barrier integrity through SIRT1/SIRT3-mediated pathways. Novel delivery systems, including exosome-based carriers and nanoformulations, have shown enhanced therapeutic efficacy in overcoming bioavailability limitations. However, a critical translational gap persists between experimental promise and clinical reality. Three interconnected obstacles impede progress: the complete absence of human clinical trials in intestinal I/R contexts, poor pharmacokinetics characterized by extensive first-pass metabolism that raises fundamental questions about achievable therapeutic tissue concentrations, and the lack of large animal validation studies bridging rodent models and human pathophysiology. This review provides critical analysis of evidence quality, identifies specific knowledge gaps, and proposes a structured translational roadmap prioritizing clinically relevant post-ischemic treatment paradigms, comprehensive pharmacokinetic ch
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater